Back to Search
Start Over
Corrigendum: CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond.
- Source :
- Frontiers in Immunology; 11/20/2018, pN.PAG-N.PAG, 1p
- Publication Year :
- 2018
Details
- Language :
- English
- ISSN :
- 16643224
- Database :
- Complementary Index
- Journal :
- Frontiers in Immunology
- Publication Type :
- Academic Journal
- Accession number :
- 133121096
- Full Text :
- https://doi.org/10.3389/fimmu.2018.02606